Hochschulschrift
Identification and functional analysis of the LIM domain protein CRP2, a marker of hepatic stellate cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
197 Bl. in getr. Zählung
- Sprache
-
Englisch
- Anmerkungen
-
Ill., graph. Darst.
Aachen, Techn. Hochsch., Habil.-Schr., 2001
- Urheber
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Ähnliche Objekte (12)
Established Hepatic Stellate Cell Lines in Hepatology Research
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Weiskirchen, Ralf [Hrsg.] ; Friedman, Scott L. [Hrsg.]: Hepatic Stellate Cells. - New York, NY, 2023. - ISBN 978-1-07-163206-2; DOI: 10.1007/978-1-0716-3207-9
Insights in Gastrointestinal and hepatic pharmacology: 2021
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021
The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels
Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis
Exercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic Injury
Established Hepatic Stellate Cell Lines in Hepatology Research
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Weiskirchen, Ralf [Hrsg.] ; Friedman, Scott L. [Hrsg.]: Hepatic Stellate Cells. - New York, NY, 2023. - ISBN 978-1-07-163206-2; DOI: 10.1007/978-1-0716-3207-9
Insights in Gastrointestinal and hepatic pharmacology: 2021
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021
The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels
Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis
Exercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic Injury
Established Hepatic Stellate Cell Lines in Hepatology Research
Physalin B attenuates liver fibrosis via suppressing LAP2 alpha-HDAC1 mediated deacetylation of glioma-associated oncogene 1 and hepatic stellate cell activation
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis"
Special Issue on "Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis II"
Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
Differentielle Genaktivität in v-myc-transformierten Wachtelfibroblasten
Weiskirchen, Ralf [Hrsg.] ; Friedman, Scott L. [Hrsg.]: Hepatic Stellate Cells. - New York, NY, 2023. - ISBN 978-1-07-163206-2; DOI: 10.1007/978-1-0716-3207-9
Insights in Gastrointestinal and hepatic pharmacology: 2021
Editorial: Insights in Gastrointestinal and Hepatic Pharmacology: 2021
The hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels
Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis